A randomized controlled trial of a web-based treatment for social phobia

ISRCTN ISRCTN62304985
DOI https://doi.org/10.1186/ISRCTN62304985
Secondary identifying numbers 100011-112345
Submission date
05/03/2007
Registration date
26/09/2007
Last edited
23/05/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Prof Franz Caspar
Scientific

40 Blv. du Pont d'Arve
Geneva
1211
Switzerland

Email franz.caspar@pse.unige.ch

Study information

Study designRandomised controlled trial.
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific titleA randomized controlled trial of a web-based treatment for social phobia
Study acronymOSP Trial (Online Social Phobia Trial)
Study objectivesTo determine whether a new, web-based version of cognitive therapy is an effective treatment for social phobia.
Ethics approval(s)Approved by the Swiss National Science Foundation on 1 April 2006.
Health condition(s) or problem(s) studiedSocial phobia
Intervention1. Web-based cognitive-behavioral treatment (10 weeks)
2. 10 week wait-list control condition
Patients initially allocated to wait will subsequently receive the web-based cognitive-behavioral treatment.
Intervention typeOther
Primary outcome measureThe following will be performed at pre-assessment (baseline), post-assessment (at 10 weeks) and follow-up (at 6 months):
1. Social Phobia Scale
2. Social Interaction Scale
3. Liebowitz Social Anxiety Scale
Secondary outcome measuresThe following will be performed at pre-assessment (baseline), post-assessment (at 10 weeks) and follow-up (at 6 months):
1. Symptom Check List (SCL-90-R)
2. Beck Depression Inventory (BDI)
3. State-Trait Anxiety Inventory (STAI)
4. Inventory of Interpersonal Problems (IIP)
5. Goal Attainment Scaling (GAS)
Overall study start date20/03/2007
Completion date30/06/2008

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants50
Total final enrolment52
Key inclusion criteria1. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (American Psychiatric Association, 1994) criteria for social phobia. Assessed with the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders IV (SCID IV)
2. Patients are included if the cut off score is reached on the Social Phobia Scale and Social Interaction Scale
3. Age 18 to 35
4. Willing to accept random allocation
Key exclusion criteria1. Current or past psychosis
2. Borderline personality disorder (other personality disorders are not a reason for exclusion)
Date of first enrolment20/03/2007
Date of final enrolment30/06/2008

Locations

Countries of recruitment

  • Switzerland

Study participating centre

40 Blv. du Pont d'Arve
Geneva
1211
Switzerland

Sponsor information

The Swiss National Science Foundation (Switzerland)
Government

Division I: Humanities and Social Sciences
Wildhainweg 3
Postfach 8232
Berne
3001
Switzerland

Email div1@snf.ch
Website http://www.snf.ch
ROR logo "ROR" https://ror.org/00yjd3n13

Funders

Funder type

Government

The Swiss National Science Foundation (Grant ref: 100011-112345)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/10/2009 23/05/2019 Yes No

Editorial Notes

23/05/2019: Publication reference and total final enrolment added.